170 related articles for article (PubMed ID: 38319661)
1. Prothrombin Complex Concentrate vs Conservative Management in ICH Associated With Direct Oral Anticoagulants.
Ip B; Pan S; Yuan Z; Hung T; Ko H; Leng X; Liu Y; Li S; Lee SY; Cheng C; Chan H; Mok V; Soo Y; Wu X; Lui LT; Chan R; Abrigo J; Dou Q; Seiffge D; Leung T
JAMA Netw Open; 2024 Feb; 7(2):e2354916. PubMed ID: 38319661
[TBL] [Abstract][Full Text] [Related]
2. Early Clinical and Radiological Course, Management, and Outcome of Intracerebral Hemorrhage Related to New Oral Anticoagulants.
Purrucker JC; Haas K; Rizos T; Khan S; Wolf M; Hennerici MG; Poli S; Kleinschnitz C; Steiner T; Heuschmann PU; Veltkamp R
JAMA Neurol; 2016 Feb; 73(2):169-77. PubMed ID: 26660118
[TBL] [Abstract][Full Text] [Related]
3. Association of prothrombin complex concentrate administration and hematoma enlargement in non-vitamin K antagonist oral anticoagulant-related intracerebral hemorrhage.
Gerner ST; Kuramatsu JB; Sembill JA; Sprügel MI; Endres M; Haeusler KG; Vajkoczy P; Ringleb PA; Purrucker J; Rizos T; Erbguth F; Schellinger PD; Fink GR; Stetefeld H; Schneider H; Neugebauer H; Röther J; Claßen J; Michalski D; Dörfler A; Schwab S; Huttner HB;
Ann Neurol; 2018 Jan; 83(1):186-196. PubMed ID: 29314216
[TBL] [Abstract][Full Text] [Related]
4. Blood Pressure and Anticoagulation Reversal Management during Off-Hours in Oral Anticoagulation-Associated Intracerebral Hemorrhage.
Mrochen A; Sprügel MI; Gerner ST; Sembill JA; Lang S; Lücking H; Kuramatsu JB; Huttner HB
Cerebrovasc Dis; 2020; 49(2):177-184. PubMed ID: 32320990
[TBL] [Abstract][Full Text] [Related]
5. Volume and Characteristics of Intracerebral Hemorrhage with Direct Oral Anticoagulants in Comparison with Warfarin
.
Adachi T; Hoshino H; Takagi M; Fujioka S;
Cerebrovasc Dis Extra; 2017; 7(1):62-71. PubMed ID: 28376486
[TBL] [Abstract][Full Text] [Related]
6. Andexanet alfa versus four-factor prothrombin complex concentrate for the reversal of apixaban- or rivaroxaban-associated intracranial hemorrhage: a propensity score-overlap weighted analysis.
Costa OS; Connolly SJ; Sharma M; Beyer-Westendorf J; Christoph MJ; Lovelace B; Coleman CI
Crit Care; 2022 Jun; 26(1):180. PubMed ID: 35710578
[TBL] [Abstract][Full Text] [Related]
7. Comparison of 4-factor PCC reversal of apixaban and rivaroxaban versus warfarin for intracranial hemorrhage.
Pasciolla S; Wojcik K; Kavi T; Green D; Shaikh H; Jankowitz B; Igneri LA
J Thromb Thrombolysis; 2022 Jul; 54(1):74-81. PubMed ID: 34837144
[TBL] [Abstract][Full Text] [Related]
8. Acute subdural hematoma in patients on oral anticoagulant therapy: management and outcome.
Won SY; Dubinski D; Bruder M; Cattani A; Seifert V; Konczalla J
Neurosurg Focus; 2017 Nov; 43(5):E12. PubMed ID: 29088960
[TBL] [Abstract][Full Text] [Related]
9. Intracerebral hemorrhage outcomes in patients using direct oral anticoagulants versus vitamin K antagonists: a meta-analysis.
Ahmed A; Ahmed R; Ali SS; Patel U; Shahid I; Zafar M; Sharma A; Ashraf A; Jani V
Clin Neurol Neurosurg; 2020 Nov; 198():106146. PubMed ID: 32823187
[TBL] [Abstract][Full Text] [Related]
10. Effect of prothrombin complex concentrate on hematoma enlargement and clinical outcome in patients with anticoagulant-associated intracerebral hemorrhage.
Kuwashiro T; Yasaka M; Itabashi R; Nakagaki H; Miyashita F; Naritomi H; Minematsu K
Cerebrovasc Dis; 2011; 31(2):170-6. PubMed ID: 21135553
[TBL] [Abstract][Full Text] [Related]
11. Association Between Intraventricular Alteplase Use and Parenchymal Hematoma Volume in Patients With Spontaneous Intracerebral Hemorrhage and Intraventricular Hemorrhage.
Witsch J; Roh DJ; Avadhani R; Merkler AE; Kamel H; Awad I; Hanley DF; Ziai WC; Murthy SB
JAMA Netw Open; 2021 Dec; 4(12):e2135773. PubMed ID: 34860246
[TBL] [Abstract][Full Text] [Related]
12. Association of Surgical Hematoma Evacuation vs Conservative Treatment With Functional Outcome in Patients With Cerebellar Intracerebral Hemorrhage.
Kuramatsu JB; Biffi A; Gerner ST; Sembill JA; Sprügel MI; Leasure A; Sansing L; Matouk C; Falcone GJ; Endres M; Haeusler KG; Sobesky J; Schurig J; Zweynert S; Bauer M; Vajkoczy P; Ringleb PA; Purrucker J; Rizos T; Volkmann J; Müllges W; Kraft P; Schubert AL; Erbguth F; Nueckel M; Schellinger PD; Glahn J; Knappe UJ; Fink GR; Dohmen C; Stetefeld H; Fisse AL; Minnerup J; Hagemann G; Rakers F; Reichmann H; Schneider H; Rahmig J; Ludolph AC; Stösser S; Neugebauer H; Röther J; Michels P; Schwarz M; Reimann G; Bäzner H; Schwert H; Claßen J; Michalski D; Grau A; Palm F; Urbanek C; Wöhrle JC; Alshammari F; Horn M; Bahner D; Witte OW; Günther A; Hamann GF; Hagen M; Roeder SS; Lücking H; Dörfler A; Testai FD; Woo D; Schwab S; Sheth KN; Huttner HB
JAMA; 2019 Oct; 322(14):1392-1403. PubMed ID: 31593272
[TBL] [Abstract][Full Text] [Related]
13. Direct oral anticoagulant- vs vitamin K antagonist-related nontraumatic intracerebral hemorrhage.
Tsivgoulis G; Lioutas VA; Varelas P; Katsanos AH; Goyal N; Mikulik R; Barlinn K; Krogias C; Sharma VK; Vadikolias K; Dardiotis E; Karapanayiotides T; Pappa A; Zompola C; Triantafyllou S; Kargiotis O; Ioakeimidis M; Giannopoulos S; Kerro A; Tsantes A; Mehta C; Jones M; Schroeder C; Norton C; Bonakis A; Chang J; Alexandrov AW; Mitsias P; Alexandrov AV
Neurology; 2017 Sep; 89(11):1142-1151. PubMed ID: 28814457
[TBL] [Abstract][Full Text] [Related]
14. Clinical Outcomes and Neuroimaging Profiles in Nondisabled Patients With Anticoagulant-Related Intracerebral Hemorrhage.
Lioutas VA; Goyal N; Katsanos AH; Krogias C; Zand R; Sharma VK; Varelas P; Malhotra K; Paciaroni M; Sharaf A; Chang J; Karapanayiotides T; Kargiotis O; Pappa A; Mai J; Pandhi A; Schroeder C; Tsantes A; Mehta C; Kerro A; Khan A; Mitsias PD; Selim MH; Alexandrov AV; Tsivgoulis G
Stroke; 2018 Oct; 49(10):2309-2316. PubMed ID: 30355114
[TBL] [Abstract][Full Text] [Related]
15. Comparison of 4F-PCC and aPCC time to administration and outcomes for oral anticoagulant-related ICH.
Lin S; Cunningham B; Mullen C; Simon E; Bice D; Garlock J
Am J Emerg Med; 2022 Jun; 56():183-187. PubMed ID: 35405470
[TBL] [Abstract][Full Text] [Related]
16. Impact of timing and dosing of four-factor prothrombin complex concentrate administration on outcomes in warfarin-associated intracranial hemorrhage.
Cicci CD; Weiss A; Dang C; Stanton M; Feldman R
Pharmacotherapy; 2022 May; 42(5):366-374. PubMed ID: 35384000
[TBL] [Abstract][Full Text] [Related]
17. Clinical Characteristics and Outcomes Associated With Oral Anticoagulant Use Among Patients Hospitalized With Intracerebral Hemorrhage.
Xian Y; Zhang S; Inohara T; Grau-Sepulveda M; Matsouaka RA; Peterson ED; Piccini JP; Smith EE; Sheth KN; Bhatt DL; Fonarow GC; Schwamm LH
JAMA Netw Open; 2021 Feb; 4(2):e2037438. PubMed ID: 33591368
[TBL] [Abstract][Full Text] [Related]
18. One-Year Outcome Trajectories and Factors Associated with Functional Recovery Among Survivors of Intracerebral and Intraventricular Hemorrhage With Initial Severe Disability.
Shah VA; Thompson RE; Yenokyan G; Acosta JN; Avadhani R; Dlugash R; McBee N; Li Y; Hansen BM; Ullman N; Falcone G; Awad IA; Hanley DF; Ziai WC
JAMA Neurol; 2022 Sep; 79(9):856-868. PubMed ID: 35877105
[TBL] [Abstract][Full Text] [Related]
19. Race against the clock: overcoming challenges in the management of anticoagulant-associated intracerebral hemorrhage.
Le Roux P; Pollack CV; Milan M; Schaefer A
J Neurosurg; 2014 Aug; 121 Suppl():1-20. PubMed ID: 25081496
[TBL] [Abstract][Full Text] [Related]
20. Clinical and Radiological Characteristics of Vitamin K Versus Non-Vitamin K Antagonist Oral Anticoagulation-Related Intracerebral Hemorrhage.
Miller MM; Lowe J; Khan M; Azeem MU; Muehlschlegel S; Jun-O'Connell AH; Goddeau RP; Moonis M; Gritters D; Silver B; Henninger N
Neurocrit Care; 2019 Aug; 31(1):56-65. PubMed ID: 30690686
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
